Billiontoone (NASDAQ:BLLN) Lowered to "Hold" Rating by Wall Street Zen

Key Points

• Wall Street Zen downgraded Billiontoone to “Hold” from “Buy,” while the broader analyst consensus remains “Moderate Buy,” with six Buy, three Hold, and one Sell rating and an average price target of $126.71.
• Other analysts also reduced their price targets to $130, although BTIG Research, Guggenheim, and JPMorgan maintained positive ratings. Billiontoone recently reported quarterly EPS of $0.15, in line with estimates, and revenue of $109.45 million.
• The stock opened at $93.39, with a $4.30 billion market capitalization and a 52-week range of $61.96 to $150.44. Insiders sold approximately $23.5 million of shares over the past 90 days, though insiders still own 50.22% of the company.

Billiontoone (NASDAQ:BLLN - Get Free Report) was downgraded by Wall Street Zen from a "buy" rating to a "hold" rating in a report released on Saturday.

Several other research firms have also weighed in on BLLN. BTIG Research cut their target price on shares of Billiontoone from $142.00 to $130.00 and set a "buy" rating for the company in a report on Thursday. Guggenheim initiated coverage on shares of Billiontoone in a report on Monday, June 29th. They set a "buy" rating and a $125.00 price target on the stock. JPMorgan Chase & Co. cut their price objective on shares of Billiontoone from $145.00 to $130.00 and set an "overweight" rating for the company in a report on Thursday. Finally, Weiss Ratings upgraded shares of Billiontoone from a "sell (d)" rating to a "sell (d+)" rating in a research report on Tuesday, June 23rd. Six investment analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has issued a Sell rating to the company's stock. According to data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average price target of $126.71.

Billiontoone Stock Up 1.9%

Billiontoone stock opened at $93.39 on Friday. The business's 50-day moving average price is $116.49 and its 200 day moving average price is $94.28. The company has a quick ratio of 10.58, a current ratio of 11.69 and a debt-to-equity ratio of 0.17. The firm has a market cap of $4.30 billion and a price-to-earnings ratio of 133.41. Billiontoone has a 52 week low of $61.96 and a 52 week high of $150.44.

Billiontoone (NASDAQ:BLLN - Get Free Report) last announced its quarterly earnings results on Wednesday, August 5th. The company reported $0.15 earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of $0.15. Billiontoone had a return on equity of 9.96% and a net margin of 8.04%.The company had revenue of $109.45 million during the quarter. As a group, sell-side analysts anticipate that Billiontoone will post 0.92 earnings per share for the current year.

Insiders Place Their Bets

In related news, CTO David Tsao sold 20,000 shares of the business's stock in a transaction on Monday, June 15th. The shares were sold at an average price of $102.27, for a total value of $2,045,400.00. Following the completion of the sale, the chief technology officer owned 1,000 shares of the company's stock, valued at approximately $102,270. The trade was a 95.24% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Shan Riku Sakakibara sold 8,000 shares of the company's stock in a transaction on Wednesday, June 24th. The stock was sold at an average price of $110.00, for a total transaction of $880,000.00. Following the transaction, the insider owned 208,000 shares of the company's stock, valued at $22,880,000. This represents a 3.70% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders sold 202,049 shares of company stock valued at $23,496,861. Corporate insiders own 50.22% of the company's stock.

Institutional Trading of Billiontoone

A number of institutional investors and hedge funds have recently modified their holdings of the stock. Rossby Financial LCC acquired a new stake in Billiontoone in the 4th quarter worth about $25,000. Wells Fargo & Company MN acquired a new position in shares of Billiontoone during the fourth quarter valued at approximately $76,000. Smartleaf Asset Management LLC acquired a new position in shares of Billiontoone during the fourth quarter valued at approximately $80,000. Nano Cap New Millennium Growth Fund L P purchased a new position in shares of Billiontoone in the fourth quarter valued at approximately $82,000. Finally, Thrive Wealth Management LLC purchased a new position in shares of Billiontoone in the second quarter valued at approximately $240,000.

Billiontoone Company Profile

BillionToOne NASDAQ: BLLN is a molecular diagnostics company that develops and commercializes high-precision genetic testing solutions based on single-molecule counting technology. The company’s platform is designed to detect and quantify rare genetic variants and chromosomal abnormalities from cell-free DNA, with a primary focus on applications in prenatal screening and other clinical genetic tests where sensitivity and specificity at very low allele fractions are critical.

BillionToOne’s offerings center on assay development and clinical testing workflows that enable non-invasive prenatal testing (NIPT) and targeted molecular diagnostics.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source